Atrial fibrillation: Difference between revisions
Varun Kumar (talk | contribs) mNo edit summary |
Varun Kumar (talk | contribs) mNo edit summary |
||
| Line 75: | Line 75: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Electrocardiography}} | {{Electrocardiography}} | ||
{{Circulatory system pathology}} | {{Circulatory system pathology}} | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Revision as of 13:33, 30 October 2011
| Atrial fibrillation | |
| ICD-10 | I48 |
|---|---|
| ICD-9 | 427.31 |
| DiseasesDB | 1065 |
| MedlinePlus | 000184 |
|
Atrial Fibrillation Microchapters | |
|
Special Groups | |
|---|---|
|
Diagnosis | |
|
Treatment | |
|
Cardioversion | |
|
Anticoagulation | |
|
Surgery | |
|
Case Studies | |
|
Atrial fibrillation On the Web | |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and related keywords: AF, Afib, fib, PAF, paroxysmal afib, Lone fibrillator
Overview
Pathophysiology
Epidemiology and demographics
Risk Factors
Diagnosis
Symptoms | Screening | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X ray | Echocardiography | Holter monitoring | Exercise stress testing
Treatment
Urgent treatment
Overview and General Treatment Strategies
Anticoagulation
Atrial fibrillation anticoagulation | Warfarin | Dabigatran
Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants
Dabigatran: Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Rate Control
Maintenance of Sinus Rhythm | Rate Control | Cardioversion | Invasive Treatment | Surgical Treatment
Special Considerations
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hyperthyroidism | Pregnancy | Hypertrophic Cardiomyopathy | Pulmonary Diseases
Follow-Up and Secondary Prevention
Overview
Clinical Trial Data
Overview
Vote on and Suggest Revisions to the Current Guidelines
Guideline Resources
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation [2]
- ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter [3]
Related Chapters
External links
- American Heart Association's page on atrial fibrillation
- Atrial fibrillation
- Bandolier: Evidence-based medicine resource on atrial fibrillation
References
- ↑ Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (7):e257-354. DOI:10.1161/CIRCULATIONAHA.106.177292 PMID: 16908781
- ↑ Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123 (10):e269-367. DOI:10.1161/CIR.0b013e318214876d PMID: 21382897
- ↑ Estes NA, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS et al. (2008) ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society. Circulation 117 (8):1101-20. DOI:10.1161/CIRCULATIONAHA.107.187192 PMID: 18283199
de:Vorhofflimmern it:Fibrillazione atriale nl:Boezemfibrilleren no:Atrieflimmer fi:Eteisvärinä